Cargando…
Implementation of principles of pharmacoeconomics and pharmacovigilance to achieve optimal financial and therapeutic benefits through WHO - Essential medicine policy and adoption of NLEM-Based hospital formulary policy
CONTEXT: WHO in its development of the roadmap on access to medicines and vaccines 2019–2023 has emphasized that the greatest challenge in achieving Universal Health Coverage (UHC) stem from persistent barriers to accessing health services and to accessing affordable and quality assured health produ...
Autores principales: | Saravdekar, Suresh, Shukla, Vijay K., Upadhya, Omprakash P., Rai, Madhukar, Giri, Kiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6618235/ https://www.ncbi.nlm.nih.gov/pubmed/31334167 http://dx.doi.org/10.4103/jfmpc.jfmpc_287_19 |
Ejemplares similares
-
Formulary Management Methods and Pharmacoeconomics
por: Curtiss, Frederic R.
Publicado: (2003) -
Drug Policy Research & Pharmacoeconomics
Publicado: (2008) -
On the Use of Markov Models in Pharmacoeconomics: Pros and Cons and Implications for Policy Makers
por: Carta, Andrea, et al.
Publicado: (2020) -
The National List of Essential Medicines of India 2022 (NLEM 2022): Tommy, Toe the Line
por: Manikandan, S.
Publicado: (2023) -
Comparison of tiered formularies and reference pricing policies: a systematic review
por: Morgan, Steve, et al.
Publicado: (2009)